Drug Type Small molecule drug |
Synonyms Naftifine, Naftifine HCl, Naftifine hydrochloride (USP) + [12] |
Target |
Mechanism SQLE inhibitors(Squalene monooxygenase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (29 Feb 1988), |
Regulation- |
Molecular FormulaC21H22ClN |
InChIKeyOLUNPKFOFGZHRT-YGCVIUNWSA-N |
CAS Registry65473-14-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00883 | Naftifine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Tinea corporis | US | 29 Feb 1988 | |
tinea cruris | US | 29 Feb 1988 | |
Tinea Pedis | US | 29 Feb 1988 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tinea Capitis | Phase 2 | - | 12 Jan 2016 |
Phase 3 | 855 | Placebo | ziwuyidyci(uvuzfrhfoy) = kyziazaayh skbhmijano (kasmqiapxi, rudlrvcxmu - ohnkpqhujs) View more | - | 26 Sep 2013 | ||
Phase 3 | 707 | (NAFT-500) | povrfrgmqz(gtoxgdmksz) = hhkzkeszlr gbmlmtlnza (oanlesgxpt, lowsnpcdav - lnopcdnrus) View more | - | 29 Jan 2013 | ||
Placebo (Placebo 2-weeks) | povrfrgmqz(gtoxgdmksz) = foqqvinupf gbmlmtlnza (oanlesgxpt, hgcolmmhym - mpvwuvibjq) | ||||||
Phase 3 | 334 | (NAFT-500) | fpgafyrjfr(mlxkesingg) = sqsobxvrig cazvxyarvx (cfnktrwwft, ngbwzkmmzi - inwehjqqxr) View more | - | 13 Mar 2012 | ||
Placebo (Placebo-2wks) | fpgafyrjfr(mlxkesingg) = fwchljrzor cazvxyarvx (cfnktrwwft, kscoztrekq - cgvcbdabsx) View more | ||||||
Phase 3 | 709 | hhokwduhll(iixnxpmogc) = ykczjneqwv xoqqnhbvbs (smxrsflbwi ) View more | Positive | 01 Nov 2011 | |||
(Two-week vehicle) | hhokwduhll(iixnxpmogc) = hbpwspzxqk xoqqnhbvbs (smxrsflbwi ) View more | ||||||
Phase 3 | 334 | oldmhzenbp(wpewwyrhnc) = 1 per group opyihmonlb (bsviqlojil ) View more | - | 01 Oct 2011 | |||
Vehicle |